Gupta Amit sold $54K of CDLX
Gupta Amit (Chief Executive Officer) sold 13,461 shares of Cardlytics, Inc. (CDLX) at an average of $4.00 ($3.97–$4.03) across 2 trades over 2026-08-17 to 2026-08-18.
How this was made
The 30-second read
Why it matters
The disclosure provides a new datapoint on insider selling activity, but it does not include any new company performance, guidance, or deal information.
Market read
Traders may monitor for follow-on insider activity or corroborating company news, but this filing alone is unlikely to drive a major repricing.
What to watch
The filing does not state motivations, tax needs, or whether sales were planned; without follow-on insider buys or company news, trading impact is likely muted.
Background
The article reports an SEC Form 4 insider transaction by Cardlytics CEO Amit Gupta.
Ticker impact
Cardlytics CEO Amit Gupta sold 13,461 shares in open-market trades at about $3.97 to $4.03, per a fresh SEC Form 4 filing.
Likely limited near-term impact; any effect would be sentiment-driven and small unless paired with other disclosures.
The article is a primary-source Form 4 showing an open-market sale by the CEO, with no guidance, financial results, or regulatory/contract developments included.
Market effects
No clear sector read-through from a single insider open-market sale without additional context.
None indicated.
None indicated.
Counterpoint
Insider sales can be routine liquidity events, especially without a 10b5-1 plan disclosed here, so the signal may be overstated.
Key entities
- issuerCardlytics, Inc.
Subject of the Form 4 insider transaction; CEO Amit Gupta sold shares in open-market trades.
- insiderAmit Gupta
Cardlytics CEO and director who executed the reported sales.
